Additional file 1 of Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration

Additional file 1: Table S1. Clinical characteristics of TCGA, GSE13507, and IMvigor210 datasets included in this study. Table S2. List of Reactome glycolysis and cholesterol-biosynthesis gene sets. Table S3. List of co-expressed glycolysis and cholesterol biosynthesis genes identified by consensus clustering. Table S4. Multivariate Cox regression determining the association between metabolic subtypes and overall survival. Table S5. Frequency of SNV and indels mutation of the 20 co-expressed glycolytic and cholesterogenic genes in the TCGA dataset. Table S6. Frequency of CNV alterations of the 20 co-expressed glycolytic and cholesterogenic genes in the TCGA dataset. Table S7. Frequency of genetic alterations of the 30 most frequently altered genes across the 4 metabolic subtypes of bladder cancer in the TCGA dataset. Table S8. Correlations between expression of glycolytic and cholesterogenic genes and the 30 most frequently altered genes in TCGA dataset.